Excerpt from Raymond James strategist Jeffrey Saut's latest essay:
As for investment positions, while some of our recommendations have
been stopped-out (read: sold), due to our “sell discipline” designed to
manage the downside risk, others have done just fine. One that did okay
until last Friday’s earnings “hairball” is Microsoft (MSFT). We
have often spoken about MSFT since hearing its story (see previous
missives) from a particularly prescient portfolio manager [PM] at our
March institutional conference. At the time the shares were changing
hands around $28. If participants followed our strategy of
scale-buying, they should have an average-weighted cost basis of around
$29. Given that our fundamental research correspondents are re-thinking
their ratings, we are using a $26 stop-loss point for this investment
recommendation.
Clearly this year has proven to be a difficult investing
environment. Still, we continue to fair pretty well with our trading
recommendations, as well as our investment names like Delta Petroleum
(DPTR), Schering-Plough’s (SGP)
8%-yielding convertible preferred “B” shares, Covanta
(CVA); and don’t look now, but Strong Buy-rated
Cogent (COGT) “gapped” above its 50-DMA last Friday on big
volume.